It is just a matter of finding them. Garcinia Cambogia is an Indonesian plant that resembles a pumpkin. Found in Asia, this fruit has been used for centuries in traditional medicine, to treat a variety of diseases. This plant is mostly known for its energy-boosting and appetite-suppressing properties, this is why many manufacturers have started to use Garcinia Cambogia extract in their weight loss supplements. The secret lies in the active ingredient in Hydroxycitric Acid – HCA, which has several different effects on the body. HCA plays a pivotal role in the weight loss process, as it prevents the body from storing carbohydrates under the form of fat.
For the original version including any supplementary images or video, visit http://www.auto-mobi.info/content/view/633130/57/
Weight Reduction Decreases Atrial Fibrillation, Symptom Severity
“Atrial fibrillation has been described as the epidemic of the new millennium, with a projection that by 2050 there will be 12 million to 15 million affected individuals in the United States. In the United States, the direct economic cost of atrial fibrillation is estimated at $6 billion annually. Although population aging is regarded as an important contributor, obesity may account for a substantial proportion of the increasing prevalence,” according to background information in the article. Whether weight reduction miracle garcinia cambogia and cardiometabolic risk factor management can reduce the burden of atrial fibrillation has not been known.
For the original version including any supplementary images or video, visit http://medicalxpress.com/news/2013-11-weight-reduction-decreases-atrial-fibrillation.html
Weight reduction decreases atrial fibrillation and symptom severity
Whether weight reduction and cardiometabolic risk factor management can reduce the burden of atrial fibrillation has not been known. The study was conducted between June 2010 and December 2011 among overweight and obese patients with symptomatic atrial fibrillation. Patients underwent a median (midpoint) of 15 months of follow-up. Patients were randomized to weight management (intervention; n = 75) or general lifestyle advice (control; n = 75). Both groups underwent intensive management of cardiometabolic risk factors (hypertension, hyperlipidemia, glucose intolerance, sleep apnea, and alcohol and tobacco use).
For the original version including any supplementary images or video, visit http://www.sciencedaily.com/releases/2013/11/131117155729.htm